000 02688nam  2200409zi 4500
0019.921499
003CaOODSP
00520231005083350
006m     o  d f      
007cr cn|||||||||
008230404t20222023onco    o    f100 0 eng d
020 |a9780660482828|z9780660482842
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aMR4-139/2023E-PDF|zMR4-139/2023F-PDF
24500|aOperating grant : |bevaluation of harm reduction approaches to address the opioid crisis in the context of COVID-19 - supervised consumption sites evaluation : end-of-grant virtual workshop - what we heard report.
264 1|aOttawa, ON : |bCanadian Institutes of Health Research = Instituts de recherche en santé du Canada, |c2022.
264 4|c©2023
300 |a1 online resource (16 pages) : |bphotographs
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |a"Workshop Date: October 28, 2022."
500 |a"Location: Virtual Meeting via MS Teams."
500 |aIncorrect catalogue number (MR4-139/2023F-PDF) and ISBN (9780660482842) printed in this publication.
500 |aIssued also in French under title: Subvention de fonctionnement : évaluation des approches de réduction des méfaits face à la crise des opioïdes dans le contexte de la COVID-19 - évaluation des sites de consommation supervisée - atelier virtuel de fin de subvention - compte rendu.
520 |a"On October 28, 2022, the Canadian Institutes of Health Research (CIHR) hosted a virtual end-of-grant knowledge exchange workshop for four one-year supervised consumption sites (SCS) evaluation projects funded through the Operating Grant : Evaluation of Harm Reduction Approaches to Address the Opioid Crisis in the Context of COVID-19 funding opportunity. This report comprises a synthesis of the evidence presented by the four research teams and a summary of knowledge user and audience perspectives shared during a panel reflections and discussion session"--Introduction, page 4.
650 0|aOpioids|xOverdose|xResearch|zCanada|vCongresses.
650 0|aDrug abuse|xSocial aspects|zCanada|vCongresses.
650 0|aCOVID-19 (Disease)|xSocial aspects|zCanada|vCongresses.
655 7|aConference papers and proceedings|2lcgft
7102 |aCanadian Institutes of Health Research, |eissuing body.
77508|tSubvention de fonctionnement : |w(CaOODSP)9.921502
85640|qPDF|s717 KB|uhttps://publications.gc.ca/collections/collection_2023/irsc-cihr/MR4-139-2023-eng.pdf
8564 |qHTML|sN/A|uhttps://cihr-irsc.gc.ca/e/53469.html